Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 200 shares, a decrease of 87.5% from the February 13th total of 1,600 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 0.1 days.
Mayne Pharma Group Stock Performance
Shares of MAYNF remained flat at $2.49 during mid-day trading on Friday. 500 shares of the company were exchanged, compared to its average volume of 1,360. Mayne Pharma Group has a 12-month low of $2.00 and a 12-month high of $5.87. The company has a 50-day moving average of $2.32 and a two-hundred day moving average of $3.15.
Get
Mayne Pharma Group alerts:
About Mayne Pharma Group
(Get Rating)
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products.
Featured Stories
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
梅恩製藥集團有限公司(場外交易市場代碼:MAYNF-GET Rating)是2月份空頭股數價格大幅下降的接受者。截至2月28日,空頭股數共有200股,比2月13日的1,600股減少了87.5%。以日均成交量1,500股計算,目前天數與回補比率為0.1天。
梅恩製藥集團股票表現
在週五午盤交易中,MAYNF的股價持平於2.49美元。該公司成交量為500股,而其平均成交量為1,360股。Mayne Pharma Group的12個月低點為2.00美元,12個月高位為5.87美元。該公司的50日移動均線切入位在2.32美元,200日移動均線切入位在3.15美元。
到達
梅恩製藥集團警報:
關於梅恩製藥集團
(獲取評級)
梅恩製藥集團有限公司從事專利和仿製藥的開發和製造。它通過以下部門開展業務:仿製產品、特殊產品、公制合同服務和梅恩製藥國際公司。仿製藥部門涉及仿製藥和品牌藥品的製造和分銷。
專題報道
- 免費獲取StockNews.com關於Mayne Pharma Group(MAYNF)的研究報告
- 2個近海鑽探公司將大賺一筆
- 未來有望實現兩位數上漲的三隻史泰博股票
- 投資者能信任消費者來提升美國戶外品牌嗎?
- 如何購買高收益股利股票
- 甲骨文已表示:股價下跌5%
接受Mayne Pharma Group Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Mayne Pharma Group和相關公司的最新新聞和分析師評級的每日簡要摘要。